Impact of Photoactivated Curcumin on Proliferation of Experimentally Induced Periodontitis and Diabetic Gingival Fibroblast Cell Line Authors: Ananya Sharma, Vivek Kumar Bains, Chetan Chandra, Ruchi Srivastava, Sunakshi Soi, Utkarsh Singh, Aditya Bhushan Pant Published: 2024 ABSTRACT ABSTRACTObjective:To evaluate the impact of photoactivated curcumin on proliferation of experimentally induced periodontitis and diabetic gingival fibroblast in laboratory settings.Materials and Methods:Gingival fibroblast (GF) cells were divided into healthy GF (HGF), diabetic GF (DGF), and periodontitis-associated diabetic GF (P-DGF) cells that were treated with a solution of curcumin that was prepared and diluted in autoclave distilled water to obtain a concentration used (1 mg/ml). Gingival fibroblasts with curcumin and without curcumin were seeded in a 96-well plate that was treated with a light-emitting diode curing light with a wavelength of 445 nm using a transparent diffuser tip. All healthy (HGF) as well as diseased (DGF and P-DGF) gingival fibroblasts were thus treated with curcumin (c-only), photoactivation (p-only), and both photoactivated curcumin (pc-both) and were then histologically analyzed for evaluation of cell proliferation and viability of fibroblasts. The number of proliferated cells/proliferative values were calculated by relative fluorescence values displayed by a fluorimeter. The number of viable cells (%viability) correlates with the magnitude of dye reduction and expressed as percentage of Alamar-Blue reduction.Results:HGF group treated with p-alone, c-alone, and pc-both showed a significant increase in the fluorescence value and proliferation in the cells at 24 to 48 and 48 to 72 h, whereas for the DGF group, there was a statistically significant increase in the fluorescence value and proliferation when treated with p-alone from 24 to 72 h, with a significant decrease in the proliferation of the cells when treated with c-alone and pc-both at 24 to 48 h and 48 to 72 h. For the P-DGF group, a significant decrease in the fluorescence value and proliferation was observed when the cells were treated with p-alone and c-alone at 24 to 72 h.Conclusion:Photoactivation (p-alone) was the most efficient in depicting a highly significant increase in the percentage viability for the group P-DGF and DGF at 24 h, whereas a significant increase in the fluorescence value and proliferation was observed for the group P-DGF when treated with photoactivated curcumin (pc-both) from 24 to 72 h. INTRODUCTION Diabetes mellitus (DM) is a group of metabolic disorders and is one of the most significant diseases in the developed world, affecting more than 170 million people. In 2000, India (31.7 million) had the maximum number of people with DM, followed by China, with 20.8 million diabetic population, and then the United States (17.7 million) in the second and third places, respectively.[12] Periodontitis, being the sixth complication of DM, has bidirectional relationship with diabetes.[3] Studies have suggested that oxidative stress is the connecting link between diabetes and periodontitis, and it is a pathogenic factor in diabetic complications as well as associated with potential tissue damage in periodontal diseases. Patients with diabetes have elevated levels of advanced glycation end products in their gingival tissues that may be associated with a state of enhanced oxidative stress, a potential mechanism for accelerated tissue damage.[4] Fibroblasts, being the most abundant cell type in connective tissue, are involved in producing and remodeling of the periodontal extracellular matrix and thus have an important role in periodontal tissue breakdown. Various studies have used fibroblasts exposed to 25–50 mM glucose and 1 ng/ml of lipopolysaccharides, respectively, as the standard experimental protocol for mimicking the diabetic and periodontally diseased conditions in laboratory settings.[56] Curcumine is a bioactive compound derived from the turmeric plant (Curcuma Longa). Its application in the field of dentistry, especially in the treatment of periodontal disease, has shown promising results, primarily due to its ability to modulate inflammatory pathways and microbial communities.[7] Despite its potential, curcumin’s clinical application is hindered by poor bioavailability and limited tissue absorption. Being a fat-soluble hydrophobic photosensitizer, it is activated by absorbing blue light (445 nm) and produces reactive oxygen species (ROS). Photoactivation of curcumin using a blue light-emitting diode (LED) has been shown to reduce the inflammatory process severity and controlled bone loss by reduction of osteclastic recruitment and activity and increases the wound healing; thus, photoactivation has emerged as a novel method to enhance curcumin’s therapeutic effect.[8] Although photoactivated curcumin has been used by many researchers for management of periodontitis[9] as well as diabetes-induced periodontitis.[10] However, the specific impact of photoactivated curcumin on the cellular mechanisms underlying periodontitis, particularly in diabetic conditions that alter gingival fibroblast (GF) function, remains uninvestigated. Furthermore, GFs are key to maintaining periodontal tissue health, and compromised activity in diabetes patients contributes to the excerbated course of periodontal disease. To the best of authors’ knowledge, no published literature has reported the impact of photoactivation of curcumin on periodontitis-induced GF proliferation. Therefore, the present study was aimed to evaluate the impact of photoactivated curcumin on proliferation of experimentally induced periodontitis and diabetic GF in laboratory settings. MATERIALS AND METHOD The present study was conducted in the Department of Periodontology, in collaboration with the Indian Institute of Toxicology Research from December 2019 to November 2021. The study protocol was conducted in accordance with the ethical principles described in the Declaration of Helsinki 1998 revised 2013 after approval from the Institutional Research and Development Committee (IRDC). For the present in vitro study, experimental models were used to imitate clinically healthy, periodontal disease, and DM conditions as shown in Figure 1. Flow chart showing classification of control group and experimental/test groups Experimental model: The materials used for this experiment were commercially available curcumin powder (99% Pure Curcumin, Sigma Aldrich, St. Louis, US), GF cell line (Continuous cell line, Piracicaba Dental School, UNICAMP, Brazil), and lipopolysaccharide (Sigma, St. Louis, MO, USA). The concentration of curcumin used in this experiment was 1 mg/ml, and the lipopolysaccharide (LPS) concentration used was 10 ng/ml. Healthy gingival fibroblast (HGF) cell line: For the experiment, continuous GF cell lines routinely maintained in the laboratory were used and cultured.[11] Each HGF sample (continuous cell line) was washed four times with phosphate-buffered saline (PBS). The cells were centrifuged at 800 rpm (Heraeus Biofuge Stratos Centrifuge) at room temperature. The cells were then resuspended and plated onto T25 flasks and cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 20% fetal bovine serum (FBS) and 1% antibiotics, and the cells were incubated at 37°C in a humidified atmosphere of 5% CO2 in an incubator (Binder, D-78532, Tuttlingen, Germany). The HGFs were then seeded in 90 wells at a density of 10,000 cells/well in triplicates in a 96-well plate. A total of three such 96-well plates were prepared for evaluation of cell viability and proliferation at 24, 48, and 72 h. The HGF cells without any treatment served as control (Ct) and were denoted as HGF-Ct in the well plate. Diabetic gingival fibroblast (DGF) cell line: DGF cell lines for the experiment were prepared at 25 mM concentration to mimic hyperglycemic conditions.[5] HGF cell lines prepared (as described above) were subjected to hyperglycemic conditions by exposing them to DMEM supplemented with 25 mM glucose for 48 h before treatment day to mimic the diabetic conditions in a patient. The cells were passaged in a high-glucose medium up to five passages before using them for experimentation. The cell lines obtained after passage 5 were used as DGF. Periodontitis induced Diabetic gingival fibroblast (P-DGF) cell line: To induce experimental periodontitis in DGF cell lines, pretreated DGF cells, after culturing in 10% FBS culture media for 24 h, were starved in serum-free media for another 24 h. After washing twice with PBS, fibroblasts were exposed to a serum-free medium with 1 ng/ml LPS, which was read as blue in color by the Alamar Blue (AB) cell viability reagent in the seeded wells.[12] Photoactivation (p-only): In order to perform photoactivation, the healthy (HGF), diabetic (DGF), and P-DGF cells seeded in the 96-well plate were treated with a LED curing light (Woodpecker I LED, curing light, Guilin Woodpecker Medical Instrument Co., Ltd.) with a wavelength of 445 nm using a transparent diffuser tip. The light was applied for 5 minutes to each well of the 96-well plate. The dose delivery was approximated because different areas and several distances were irradiated. The groups treated with photoactivation were denoted as follows: HGF(p): photoactivated HGF, DGF(p): photoactivated DGF, and P-DGF(p): photoactivated P-DGF. Curcumin Application (c-only): For evaluating the effect of curcumin on healthy, diabetic, and periodontitis-associated diabetic gingival fibroblasts, a solution of curcumin was prepared and diluted in autoclave distilled water to obtain a concentration used (1 mg/ml). Cells were exposed to a concentration of 1 mg/ml of curcumin, which was read as pink in color by the AB cell viability reagent in the seeded wells. The groups treated with curcumin were denoted as follows: HGF(c): curcumin-treated HGF, DGF(c): curcumin-treated DGFs, and P-DGF(c): curcumin-treated P-DGF. Photoactivated curcumin (pc-both): For the healthy, diabetic, and periodontitis-associated diabetic gingival fibroblasts, blue LED curing light (445 nm) was exposed to GF cells pretreated with curcumin for evaluation of proliferation and viability for 24, 48, and 72 h. The groups treated with photoactivated curcumin were denoted as follows: HGF (pc): photoactivated curcumin-treated HGF, DGF (pc): photoactivated curcumin-treated DGF, and P-DGF (pc): photoactivated curcumin-treated P-DGF. Histological analyses for evaluation of cell proliferation and viability of fibroblasts: Briefly, an equal number (10,000 cells/well) of GF cells were seeded in 90 wells of 96-well plates. Culture media of the experimental groups HGF(p), DGF(p), and P-DGF(p) were exposed to blue LED curing light (445 nm) and assessed at 24, 48, and 72 h. For experimental groups, (HGF(c), DGF(c), and P-DGF(c)), GF cells were exposed to a concentration of 1 mg/ml of curcumin at the day of treatment and parameters were evaluated at 24, 48, and 72 h. For the experimental groups HGF (pc), DGF (pc), and P-DGF (pc), photoactivation of curcumin was achieved using blue LED curing light (445 nm) and proliferation and % viability of cells was done using AB assay as discussed below. Assessment by Alamar Blue Assay (Fluorescence Spectroscopy): Effects of photoactivation, curcumin, and photoactivated curcumin on cell lines were evaluated by the Alamar Blue (Invitrogen, Carlsbad, CA, USA) viability assay. Freshly prepared serum-free DMEM containing 10% of AB solution was added to the wells after the incubation periods of 24, 48, and 72 hours. Cells were then further incubated for 4 h at 37°C and 5% of CO2. After this period, cell viability was determined according to the fluorescence intensity of AB solution in a fluorimeter (Synergy H1 BioTek, Winooski, VT, USA; excitation of 560 nm and emission of 590 nm). The fluorimeter detector displays the fluorescence value and produces the fluorescence signature of the cells. The cell activity was identified by detecting the fluorescence emission. The intensity of the fluorescence indicates the cell growth; the higher the intensity value, the higher is the cell activity. Fluorescence is monitored at 530–560 nm excitation wavelength and 590 nm emission wavelength as used in this study. Calculation of proliferation: The number of proliferated cells/proliferative values is calculated by relative fluorescence values (RFVs) displayed by the fluorimeter. The mean of the florescence values correlates with the proliferation of the cells. Calculation of percentage viability: The number of viable cells (% viability) correlates with the magnitude of dye reduction and is expressed as percentage of AB reduction. Statistical analysis Descriptive statistics were presented with mean ± standard deviation for continuous variables depending on their distribution. Categorical variables were described using frequency and percentages. The degree of freedom was calculated after application of each statistical test. Inferential statistics were performed using Chi-square test and Mann–Whitney U Test. Intergroup comparison of mean percentage of GF proliferation was done and viability at varying time periods was calculated by one-way analysis of variance (ANOVA). The confidence interval was kept at 95%. The level of statistical significance was set at 0.05. RESULTS The present in vitro study deals with the evaluation of impact of photoactivated curcumin on proliferation of experimentally induced periodontitis and diabetic GFs. The outcome measures of the study were proliferation and percentage viability of the cells assessed at three different time intervals (24, 48, and 72 h). At 24 h, the mean score of the group HGF(p) was more than that of the other groups, followed by HGF(c) and HGF (pc). Similarly, at 48 h, the mean score of the group HGF(p) was more than that of the other groups, followed by the mean scores of HGF (pc) and HGF(c). Group HGF(p) had the highest mean score, followed by the mean scores of HGF (pc) and HGF(c) at 72 h. At 24, 48, and 72 hours, there was a statistically significant difference between HGF(p) and HGF(c) (P < 0.0001) and also between HGF(p) and HGF (pc) (P < 0.0001) at 24, 48, and 72 h. A statistically significant difference in the mean fluorescence value was observed at 24 h (P < 0.0001), 48 h (P < 0.0001), and 72 h (P = 0.008). Group HGF showed an increase in fluorescence value at 24 h, followed by 48 h and 72 h as compared with the control (Ct) group. A statistically significant difference in the mean fluorescence value was observed at 24 h (P < 0.0001), 48 h (P = 0.017), and 72 h (P = 0.005). Group DGF showed an increase in fluorescence value at 24 h (>16,000), followed by 72 h and 48 h as compared to the Ct group. A nonsignificant difference in the mean fluorescence value was observed at 24 h (P = 0.051) and 48 h (P = 0.051), and a statistically significant difference at 72 h (P = 0.024). Group P-DGF showed an increase in fluorescence value (>10,800) at 72 h as compared with the Ct group. Percentage viability: The results for % viability using AB assay showed 100% viability of HGF for the Ct group at different time intervals, that is, 24, 48, and 72 h. The HGF(p) alone showed a nonsignificant increase in % viability within the group at 72 h as compared to 24 and 48 h, whereas % viability nonsignificantly decreased as compared to the control group at all the time intervals. Results for the group HGF(c) showed a significant increase in % viability at 24 h as compared to 48 and 72 h, where % viability decreased to less than 10% for all the cells of the group when compared to the control group. Treatment of HGF(pc) displayed a significant increase in % viability at 24 h when compared to 48 h. Cells when treated for 72 h showed a significant increase in % viability as compared to 48 h but decreased overall percent viability as compared to the control group. The DGF (p) cells showed a nonsignificant increase in % viability at 24 h when compared to cells within the group at 48 and 72 h. There was a nonsignificant increase in % viability (more than 100%) at 24 h when compared to the control group. Cells of the DGF (c) group showed a significant increase in % viability at 24 h when compared to the viability at 48 and 72 h. Cells within the group showed a highly significant decrease in % viability when compared to those of the control group. DGF(pc) group showed a highly significant decrease in % viability as compared to the control group, whereas within the same group, cells showed a significant increase in % viability at 24 h when compared to the viability of the cells at 48 and 72 h. The group P-DGF(p) showed a highly significant increase in viability of the cells at 24 h (more than 350%) when compared to the viability of the cells at 48 and 72 h as well as that of the control group. Results for the group P-DGF(c) showed a significant increase in % viability at 24 h when compared to the viability percentage at 48 and 72 h of the same group, whereas the cells of the group P-DGF(c) showed a highly significant decrease in % viability at 24, 48, and 72 h when compared to the control group. The P-DGF(pc) group resulted in a significant decrease in % viability at 24 h when compared to the control group. Cells of the same group showed a highly significant decrease in % viability at 48 h when compared to the cell’s viability at 72 h as well as the control group. The cell viability increased highly significantly at 72 h when compared to the viability at 24 and 48 h [Figure 2]. Graph showing percentage viability (Y-axis) against various groups at different time intervals (X-axis) DISCUSSION The present in vitro study was conducted to evaluate the impact of photoactivated curcumin on proliferation and percentage viability of experimentally induced periodontitis and diabetic GFs. In the present study, for evaluating the effect of curcumin on healthy, diabetic, and periodontitis-induced diabetic GFs, the cells were exposed to a solution of curcumin which was prepared and diluted in autoclave distilled water to obtain a concentration used (1 mg/ml). In contrast to previous studies,[131415] in the present study, treatment with curcumin alone resulted in a nonsignificant reduction in proliferation and percentage viability of the cells of the group HGF between 24 and 48 h. However, there was a significant increase in fluorescence value between 24 and 72 h. For the cells of the DGF group, a nonsignificant increase in the proliferation was observed in between 24 and 48 h, followed by a nonsignificant increase from 24 to 72 h, whereas a nonsignificant decrease in proliferation was observed for the P-DGF group between 24 and 72 h. Rujirachotiwat et al.[14] suggested that curcumin significantly upregulated the expression transforming growth factor (TGF)-β1, type I TGF-β receptor (TGF-βRI), type II TGF-β receptor (TGF-βRII), and vascular endothelial growth factor (VEGF) expression in unwounded human GFs and an in vitro human GF wound healing model. Photoactivation is the process of activating a substance by means of radiant energy and especially light. In the present study, healthy, diabetic, and periodontitis-associated diabetic GF cells were photoactivated (p-alone) using blue LED curing light (445 nm) for 5 minutes on each well for the evaluation of proliferation and viability for 24, 48, and 72 h. There was a significant increase in proliferation and percentage viability of the cells of P-DGF group, whereas a nonsignificant increase was observed in cells of HGF and DGF groups when treated with photoactivation alone. In a similar study, Pansani et al.[16] assessed the effects of photoactivation of cells previously exposed to LPS and connoted that photoactivation enhanced cell proliferation and viability in a time-dependent manner for cell lines exposed or not to LPS. Similarly, Prado et al.[17] also suggested that photobiomodulation with the blue light enhanced the wound healing. In the present study, for the treatment of photoactivated curcumin (pc-both) in healthy, diabetic, and periodontitis-associated diabetic GFs, curcumin was exposed to blue LED curing light (445 nm) for 5 minutes on each well for 24, 48, and 72 h. A significant increase was observed in the proliferation and percentage viability of the cells of HGF group as compared to DGF and P-DGF groups from 24 to 72 h. In a similar study, Sreedhar et al.[9] compared curcumin (c-alone) and photoactivated curcumin (pc-both) as an adjunct to conventional scaling and root planing (SRP) with SRP alone in the treatment of patients with chronic periodontitis and showed that pc-both was a valuable treatment modality adjunctive to SRP and c-alone application. In the present study, the effects of p-alone, c-alone, and pc-both on proliferation and percentage viability of cells were evaluated by the AB viability assay (Invitrogen, Carlsbad, CA, USA). Results revealed a highly significant increase in percentage viability of the cells of P-DGF group as compared to HGF and DGF groups. Khorolsuren et al.[18] also used AB® reagent to measure the cellular metabolic activity of GFs. Limitations of the study: The limitations of the present study were that only AB histological assay was used for the comparison of treatment modalities due to time constraint. Other proliferative and viability assays like 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium reduction assay (MTT assay) could also be used in near future. CONCLUSION Results of the present study suggested that all the groups (HGF, DGF, and P-DGF) showed more proliferation and percentage viability of the cells when treated with p-alone as compared to c-alone and pc-both. The present study revealed contrasting results to previous studies for the curcumin-treated group. Nevertheless, results of the present study demonstrated a significant improvement in the histological proliferation and percentage viability of the cells in the group with the treatment of p-alone; future studies should be performed to confirm if these findings are clinically relevant and related to the photoactivation of the cells. More randomized multicentric clinical trials are required to evaluate the impact of p-alone and pc on wound healing and reduction in the clinical parameters of periodontal diseases. Further, experiments regarding p-alone as a treatment modality, with focused and collimated light using light amplification of stimulated emission of radiation (LASER) in place of diffused LED curing light, are strongly suggested. Patient declaration of consent Not applicable. Data availability statement All the relevant data is included in the manuscript. Conflicts of interest There are no conflicts of interest.